JP2020516615A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516615A5 JP2020516615A5 JP2019554976A JP2019554976A JP2020516615A5 JP 2020516615 A5 JP2020516615 A5 JP 2020516615A5 JP 2019554976 A JP2019554976 A JP 2019554976A JP 2019554976 A JP2019554976 A JP 2019554976A JP 2020516615 A5 JP2020516615 A5 JP 2020516615A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- amino acid
- protein
- host cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023208379A JP2024037834A (ja) | 2017-04-07 | 2023-12-11 | 上皮バリア機能障害の治療のためのタンパク質 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762482963P | 2017-04-07 | 2017-04-07 | |
| US62/482,963 | 2017-04-07 | ||
| US201762607706P | 2017-12-19 | 2017-12-19 | |
| US62/607,706 | 2017-12-19 | ||
| US201762611334P | 2017-12-28 | 2017-12-28 | |
| US62/611,334 | 2017-12-28 | ||
| PCT/US2018/026447 WO2018187682A1 (en) | 2017-04-07 | 2018-04-06 | Proteins for the treatment of epithelial barrier function disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023208379A Division JP2024037834A (ja) | 2017-04-07 | 2023-12-11 | 上皮バリア機能障害の治療のためのタンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516615A JP2020516615A (ja) | 2020-06-11 |
| JP2020516615A5 true JP2020516615A5 (enExample) | 2021-05-13 |
| JP7789303B2 JP7789303B2 (ja) | 2025-12-22 |
Family
ID=63710147
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554976A Active JP7789303B2 (ja) | 2017-04-07 | 2018-04-06 | 上皮バリア機能障害の治療のためのタンパク質 |
| JP2023208379A Pending JP2024037834A (ja) | 2017-04-07 | 2023-12-11 | 上皮バリア機能障害の治療のためのタンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023208379A Pending JP2024037834A (ja) | 2017-04-07 | 2023-12-11 | 上皮バリア機能障害の治療のためのタンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11207376B2 (enExample) |
| EP (1) | EP3606542B1 (enExample) |
| JP (2) | JP7789303B2 (enExample) |
| KR (2) | KR20200003821A (enExample) |
| CN (1) | CN110769844B (enExample) |
| AU (2) | AU2018248324B2 (enExample) |
| CA (1) | CA3059354A1 (enExample) |
| IL (1) | IL269853A (enExample) |
| MX (2) | MX393998B (enExample) |
| SG (1) | SG11201909334TA (enExample) |
| TW (1) | TWI797116B (enExample) |
| WO (1) | WO2018187682A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11207376B2 (en) | 2017-04-07 | 2021-12-28 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11666627B2 (en) | 2017-04-07 | 2023-06-06 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| WO2019195859A1 (en) * | 2018-04-06 | 2019-10-10 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| WO2020077010A1 (en) * | 2018-10-09 | 2020-04-16 | Second Genome, Inc. | Lactococcus lactis expression system for delivering proteins efficacious for the treatment of epithelial barrier function disorders |
| JP2022544992A (ja) * | 2019-08-21 | 2022-10-24 | アストラゼネカ・コラボレイション・ベンチャーズ・リミテッド・ライアビリティ・カンパニー | クローン病を治療するためのブラジクマブの使用 |
| WO2021139766A1 (en) * | 2020-01-10 | 2021-07-15 | Huang Chih Hung | Peptide interacting with toll-like receptor 2 and the composition comprising the same |
| CN113773364B (zh) * | 2021-08-25 | 2023-04-28 | 无锡市儿童医院 | 小分子肽及其制备方法和应用 |
| EP4611774A2 (en) * | 2022-11-04 | 2025-09-10 | MiNK Therapeutics, Inc. | B-cell maturation antigen (bcma) chimeric antigen receptor invariant natural killer t cells and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5856457A (en) | 1991-03-29 | 1999-01-05 | Genentech, Inc. | Nucleic acids encoding a human IL-8 receptor |
| US6734289B2 (en) | 2001-03-29 | 2004-05-11 | The University Of Chicago | Gastrokines and derived peptides including inhibitors |
| US20060189526A1 (en) | 2002-04-24 | 2006-08-24 | Podolsky Daniel K | Compositions containing an intestinal trefoil peptide and a mucoadhesive |
| AR053579A1 (es) * | 2005-04-15 | 2007-05-09 | Genentech Inc | Tratamiento de la enfermedad inflamatoria intestinal (eii) |
| ES2568938T3 (es) | 2009-04-28 | 2016-05-05 | Vanderbilt University | Composiciones y procedimientos de tratamiento de trastornos que implican apoptosis de células epiteliales |
| GB201117313D0 (en) * | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| JP2014093482A (ja) | 2012-11-06 | 2014-05-19 | Toshiba Corp | 固体撮像装置の製造方法および固体撮像装置 |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| WO2015014973A2 (en) * | 2013-07-31 | 2015-02-05 | Institut National De La Recherche Agronomique | Use of specific glycoside phosphorylases for the implementation of phosphorolysis or reverse phosphorolysis reactions |
| EP3662917A1 (en) | 2015-06-15 | 2020-06-10 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| US11666627B2 (en) * | 2017-04-07 | 2023-06-06 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11207376B2 (en) | 2017-04-07 | 2021-12-28 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11174293B2 (en) | 2017-06-02 | 2021-11-16 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| WO2019195859A1 (en) | 2018-04-06 | 2019-10-10 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
-
2018
- 2018-04-06 US US16/603,507 patent/US11207376B2/en active Active
- 2018-04-06 KR KR1020197032830A patent/KR20200003821A/ko not_active Ceased
- 2018-04-06 CN CN201880037987.0A patent/CN110769844B/zh not_active Expired - Fee Related
- 2018-04-06 SG SG11201909334T patent/SG11201909334TA/en unknown
- 2018-04-06 US US15/947,263 patent/US10251933B2/en active Active
- 2018-04-06 JP JP2019554976A patent/JP7789303B2/ja active Active
- 2018-04-06 CA CA3059354A patent/CA3059354A1/en active Pending
- 2018-04-06 WO PCT/US2018/026447 patent/WO2018187682A1/en not_active Ceased
- 2018-04-06 AU AU2018248324A patent/AU2018248324B2/en active Active
- 2018-04-06 EP EP18781398.5A patent/EP3606542B1/en active Active
- 2018-04-06 MX MX2019012051A patent/MX393998B/es unknown
- 2018-04-06 KR KR1020237032575A patent/KR102903277B1/ko active Active
- 2018-04-09 TW TW107112165A patent/TWI797116B/zh active
-
2019
- 2019-10-06 IL IL26985319A patent/IL269853A/en unknown
- 2019-10-07 MX MX2022008842A patent/MX2022008842A/es unknown
-
2023
- 2023-04-24 US US18/305,899 patent/US12661383B2/en active Active
- 2023-05-08 AU AU2023202844A patent/AU2023202844A1/en not_active Abandoned
- 2023-12-11 JP JP2023208379A patent/JP2024037834A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020336649B2 (en) | Akkermansia muciniphila EB-AMDK19 strainand use thereof | |
| KR102140910B1 (ko) | Chp(사이클로-히스프로)를 포함하는 섬유증의 예방, 개선 또는 치료용 조성물 | |
| US20240066095A1 (en) | Proteins for the treatment of epithelial barrier function disorders | |
| US12168677B2 (en) | Proteins for the treatment of epithelial barrier function disorders | |
| WO2015007216A1 (zh) | 多肽、编码该多肽的dna分子、载体、制备方法及应用 | |
| CN102973554B (zh) | 土木香内酯在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| KR20240026882A (ko) | 락토바실러스 뮤코세 및 수용성 식이섬유의 조합물을 사용한 방법 및 조성물 | |
| US11911409B2 (en) | Pharmaceutical composition for treatment and prevention of chronic disease | |
| CN113286604A (zh) | 治疗炎症性疾病的蛋白质 | |
| JP2021514354A5 (enExample) | ||
| US12186364B2 (en) | Proteins for the treatment of epithelial barrier function disorders | |
| JP7469812B2 (ja) | 抗微生物特性を有する化合物 | |
| CN113274384B (zh) | 驴食草酚在制备防治溃疡性结肠炎的药物中的应用及其药物 | |
| WO2013004069A1 (zh) | 沙门氏菌鞭毛蛋白衍生物在制备防治炎症性肠病药物中的应用 | |
| EP3538132A1 (en) | Rectal insulin for treatment of inflammatory bowel diseases | |
| CN116492325A (zh) | 以衣康酸为起点抑制Tet靶点蛋白的药物开发 | |
| JP2009263307A (ja) | 炎症性腸疾患の予防・治療剤 | |
| CN107951898B (zh) | mir-146a-5p在治疗肠易激综合征内脏高敏感性中的应用 | |
| CN116350748A (zh) | Tigit融合蛋白在制备用于治疗系统性红斑狼疮药物中的应用 | |
| CN115429870A (zh) | 白介素40在防治中性粒细胞减少症中的应用 | |
| Warner et al. | Alcohol-induced liver injury is attenuated by human beta defensin in experimental ALD via improvements in the gut-liver axis | |
| CN113209284A (zh) | 尿胰蛋白酶抑制剂在制备治疗噬血细胞综合症药物中的用途 | |
| CN120661670B (zh) | Clic5基因在制备预防和/或治疗肠道炎症的药物中的应用 | |
| JP2020132575A (ja) | 血管新生促進剤 | |
| CN105079012A (zh) | 天麻素在制备防治溃疡性结肠炎的药物或食品中的应用 |